NCT06683534View on ClinicalTrials.gov

Palmitic Acid and Human Microvascular Function

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Microvascular DysfunctionMicrovasculatureCardiovascular DiseasesCardiovascular Diseases (CVD)Microvascular HealthObesity and Overweight
Interventions
DIETARY_SUPPLEMENT

Quercetin (dietary supplement)

Quercetin will be provided to take one Quercetin per day for 30 days to look for differences in microvascular function.

DRUG

Placebo

Subjects randomized to receive placebo will be administered a standard placebo sugar pill.

Trial Locations (1)

53226

Froedtert Hospital, Wauwatosa

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER